DS
ZVSA

David Shaw’s ZyVersa Therapeutics ZVSA Stock Holding History

David Shaw’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,106
Closed -$3.86M – 5176
2022
Q3 		$3.86M Hold
1,106
– – ﹤0.01% 2369
2022
Q2 		$3.84M Buy
1,106
+667
+152% +$2.32M ﹤0.01% 2453
2022
Q1 		$1.53M Buy
+439
New +$1.52M ﹤0.01% 3561

Other funds holding ZVSA

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

David Shaw's ZVSA Position: Q4 2022 in Review

David Shaw sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 1,106 shares — an estimated $3.86M sold.

David Shaw first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $3.86M in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

  • David Shaw reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 1,106 ZyVersa Therapeutics shares in Q4 2022, an estimated $3.86M.
  • David Shaw first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
  • David Shaw's ZyVersa Therapeutics position peaked at $3.86M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.